Affimed N.V., a clinical-stage biopharmaceutical company focused on discovering and developing targeted cancer immunotherapies, in its at-the-market offering of $50 million common shares
ARYA Sciences Acquisition Corp., a special purpose acquisition company sponsored by Perceptive Advisors and focusing on the healthcare or healthcare related industries, in its $125 million initial public offering
BofA Securities, Inc., J.P. Morgan Securities LLC and Wells Fargo Securities LLC, as representatives of the several underwriters, in connection with Visa’s $4 billion senior notes offering
Bristol-Myers Squibb in its $90 billion acquisition of Celgene and its related $13.4 billion divesture of Celgene’s OTEZLA® program to Amgen
Builders FirstSource in its $400 million senior secured notes offering and $75 million and $350 million add-on offerings
The Jordan Company in its acquisition of PulseR
